Objective: By 2030, decrease the prostate cancer mortality rate to less than or equal to 17 per 100,000 for all Ohio men in each racial/ethnic group (baseline: 2017 ODH Bureau of Vital Statistics).
Objective: By 2030, increase the percentage of males 40 years of age and older who have had a discussion with their healthcare provider about the advantages and disadvantages of the PSA (prostate-specific antigen) test from 16.5% to 25.3% (baseline: 2018 BRFSS).
Contact us if you are interested in more information on the Prostate Cancer Workgroup with OPCC.
We Always Welcome New Members
Together, we can achieve more. New members and fresh ideas are always welcome! OPCC will achieve far greater success than could be accomplished by individual organizations working alone.